Australia markets closed

BELLUS Health Inc. (BLU)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.3700-0.0500 (-1.46%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close3.4200
Open3.3800
Bid3.3500 x 800
Ask3.3900 x 800
Day's range3.3200 - 3.4350
52-week range2.0100 - 12.0300
Volume203,873
Avg. volume533,881
Market cap265.833M
Beta (5Y monthly)-0.57
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings date11 Aug 2021 - 16 Aug 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • New Strong Sell Stocks for May 25th
    Zacks

    New Strong Sell Stocks for May 25th

    AJRD, BLU, GMBL, LITE, and PSXP have been added to the Zacks Rank #5 (Strong Sell) List on May 25, 2021

  • BELLUS Health to Participate in the Jefferies Virtual Healthcare Conference
    Business Wire

    BELLUS Health to Participate in the Jefferies Virtual Healthcare Conference

    BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) ("BELLUS Health" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of refractory chronic cough ("RCC") and other hypersensitization-related disorders, today announced that Roberto Bellini, BELLUS Health's President and Chief Executive Officer, will be participating in a fireside chat at the Jefferies Virtual Healthcare Conference.

  • New Strong Sell Stocks for May 18th
    Zacks

    New Strong Sell Stocks for May 18th

    AFYA, BLU, CHRA, DHX, and EBMT have been added to the Zacks Rank #5 (Strong Sell) List on May 18, 2021